Moderate reductions in FMO3 catalytic activity (depending on the substrate) have been reported in an in vitro study using cDNA mutants [19]; the c.472G > A (p.Glu158Lys) variant was detected in patients with obvious psychiatric disease (e.g., the presence of isolated persecution ideas and interpretations). This evidence concerns the gene FMO3 and psychiatric disorder.